🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

5 recruiting trials

for Multi-system Atrophy - Parkinsonian Type

The CurePSP Genetics Program NCT06647641n/a1 site📍 Boston Massachusetts General Hospital · Tests: Whole genome sequencing will be performed at the NIH Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a2 sites📍 Sioux Falls📍 Sydney Sanford Health The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders NCT06174948NA1 site📍 London Queen Mary University of London · Tests: CUE1 non-invasive device, CUE1+ device active vs sham CUE1+ device Feasibility Study Assessing the Effect of Carbidopa/Levodopa Ratio on Orthostatic Hypotension in Multiple System Atrophy - Parkinsonian Type and Parkinson Disease. NCT06831500Phase 1, Phase 22 sites📍 Lausanne📍 Lausanne Julien Bally · Tests: Administration of Carbidopa/levodopa NYSCF Scientific Discovery Biobank NCT06203106n/a1 site📍 New York New York Stem Cell Foundation Research Institute · Tests: Biological Sample Collection
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy